Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion type Assertion NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_head.
- NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion wasGeneratedBy ECO_0000203 NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_provenance.
- NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion wasDerivedFrom befree-20140225 NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_provenance.
- NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion SIO_000772 23092582 NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_provenance.
- NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion evidence source_evidence_literature NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_provenance.
- NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_assertion description "[Our recent studies show that the crosstalk between CXCL10 and receptor activator of NF-κB ligand (RANKL) in inflamed synovial tissue may induce and perpetuate bone destruction in RA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624593.RAMobc3-TESfl--AE87nisOVy2rPZu0Jc7_MoZmXphLwE130_provenance.